Each year, approximately 60,000 Americans are diagnosed with Parkinson disease. There is no cure and few treatments are effective.
Now HudsonAlpha is embarking on a new scientific journey to improve the outcomes for these patients. The Institute is launching a research project designed to discover the genetics behind neurodegenerative diseases like Parkinson disease. Once scientists understand the genetic causes of these diseases, they can develop more effective prevention and targeted treatment strategies.
Please join us for a free Parkinson disease awareness seminar on Thursday, May 26, at 2pm at the HudsonAlpha Institute for Biotechnology. Hear from scientists who are actively researching neurodegenerative diseases, including Parkinson disease, and discover the hope that is emerging from their groundbreaking efforts.
Speakers will include:
- Rick Myers, PhD, HudsonAlpha president and science director, will share information about HudsonAlpha’s new Memory and Mobility Fund to support research of neurodegenerative diseases.
- Haydeh Payami, PhD, HudsonAlpha-UAB joint faculty, will describe progress towards personalized prevention and treatment for neurodegenerative diseases.
- Randall Moreadith, MD, PhD, president and CEO of Serina Therapeutics, will discuss his company’s new polymer drug currently in clinical trials that may provide Parkinson’s patients with much better treatment options.
Register online or call 256-327-9434. Seating is limited.
